Clinical Trial Update: Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of SP-8203 (Otaplimastat) in patients with acute ischemic stroke receiving thrombolytic therapy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SP-8203 (Otaplimastat) (Otaplimastat)

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING